Aspen Notre-Dame-de-Bondeville is an international production site that has specialised in the manufacture of sterile injectable forms since 1968.
Aspen Notre-Dame-de-Bondeville manufactures Fraxiparine™ and Arixtra™ for worldwide distribution.
All manufacturing steps are performed and checked on site, in a spirit of continuous improvement, in accordance with the systematic Lean Six Sigma approach:
- Chemical production to transform the essential raw material for the formulation of active ingredients
- Sterile filling
- Automatic inspection
- Packaging
- All the way through the shipping of syringes to our customers
Aspen Notre-Dame-de-Bondeville has the ambition to become the world leader in thrombosis drugs.
|
2 active ingredients 5 products More than 140 million units shipped each year 90% of our thrombosis drugs are exported worldwide More than 330 references shipped 3,391 production orders 677 employees Founded in 1968 Our certifications: ANVISA (Brazil), ANSM (France), EMA (Europe), FDA (USA), HPB (Canada), JMHRA (Japan) Aspen has a Management System certified by DQS for OHSAS 18001 (Health / Safety) and ISO 14001 (Environment) standards |
